title: Effect of erythropoietin therapy on serum apolipoprotein A1 levels in patients undergoing chronic peritoneal dialysis.
authors.affiliation: Department of Nephrology and Hypertension, Kaplan Medical Center, Rehovot, Israel.
authors.forename: A
authors.initials: A
authors.lastname: Kagan
authors.forename: N
authors.initials: N
authors.lastname: Haran
authors.forename: L
authors.initials: L
authors.lastname: Leschinsky
authors.forename: Z
authors.initials: Z
authors.lastname: Lerner
authors.forename: N
authors.initials: N
authors.lastname: Shuali
authors.forename: J
authors.initials: J
authors.lastname: Rapoport
mesh_terms: D000328:Adult; D000368:Aged; D000740:Anemia / Q000188:drug therapy / Q000209:etiology; D016632:Apolipoprotein A-I / Q000097:blood / Q000187:drug effects*; D003920:Diabetes Mellitus / Q000097:blood; D004921:Erythropoietin / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000628:therapy; D008297:Male; D010530:Peritoneal Dialysis / Q000009:adverse effects; D012189:Retrospective Studies
chemical_list: D016632:Apolipoprotein A-I; D004921:Erythropoietin